Join members of Formula30A's Medical Advisory Board as they discuss the results of these studies and the future of CBD (cannabidiol) research & education through Formula30A.

Medical Practitioners recently completed eight-week Observational Studies across six clinics investigating the efficacy of Formula30A Full Spectrum CBD Capsules on anxiety, insomnia, and chronic pain symptoms as measured by the GAD7 (Generalized Anxiety Disorder - 7 Item), ISI (Insomnia Severity Index), and PADT (Pain Assessment and Documentation Tool).

Our Medical Advisory Board will examine the study outcomes and discuss the implications that these findings have on the clinical application on CBD.